Incidencia de la aplicación de una unidad didáctica en el manejo del bullying, a través de la implementación de una sala de conciliación en los estudiantes de grado 5° de la Institución Educativa Cámara Junior-sede Cámara Junior

El fenómeno del bullying es una problemática que aqueja cada vez más los contextos escolares, que adquiere relevancia a nivel mundial, en Colombia ha venido aumentando, alcanzando cifras alarmantes y el contexto educativo de Armenia no es ajeno a ello. El presente proyecto de investigación pretende revelar los resultados obtenidos, a través de la implementación de una unidad didáctica, en el manejo del bullying, a través de la implementación de una sala de conciliación, en los estudiantes de Grado 5° de la Institución Educativa Cámara Junior-Sede Cámara Junior Armenia, Quindío. Lo anterior, permitió el abordaje de este fenómeno, a partir de los siguientes temas: concepto, causas, consecuencias y tipos de bullying. Así como la mediación que se puede dar entre pares, como estrategia para su manejo y/o prevención

Interculturalidad y educación desde el sur: Contextos, experiencias y voces

Interculturalidad y educación desde el Sur. Contextos, experiencias y voces es un libro colectivo que corona once trabajos de investigación realizados por diecisiete autores con diferentes adscripciones institucionales que se articulan a través de grupos de trabajo latinoamericanos en torno al debate actual sobre la Interculturalidad y Educación. Y con ello obligan al lector a pensar simultáneamente en un conjunto de movimientos o desplazamientos teórico-conceptuales, en el despliegue de posicionamientos éticos, filosóficos, políticos y jurídicos, y en el desarrollo de metodologías de investigación novedosas, que nos posibiliten revelar y actuar sobre una diversidad de experiencias, modelos y programas que buscan potenciar los procesos interculturales en el Sur. La obra en su conjunto es un aporte a la creciente producción bibliográfica que se genera en la última década desde la perspectiva crítica de Latinoamérica

Interculturalidad y educación desde el sur : contextos, experiencias y voces

Interculturalidad y educación desde el Sur. Contextos, experiencias y voces es un libro colectivo que corona once trabajos de investigación realizados por diecisiete autores con diferentes adscripciones institucionales que se articulan a través de grupos de trabajo latinoamericanos en torno al debate actual sobre la Interculturalidad y Educación. Y con ello obligan al lector a pensar simultáneamente en un conjunto de movimientos o desplazamientos teórico-conceptuales, en el despliegue de posicionamientos filosóficos, políticos y jurídicos, y en el desarrollo de metodologías de investigación novedosas, que nos posibiliten revelar y actuar sobre una diversidad de experiencias, modelos y programas que buscan potenciar los procesos interculturales en el Sur. La obra en su conjunto es un aporte a la creciente producción bibliográfica que se genera en la última década desde la perspectiva crítica de Latinoamérica

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

Abstract Background Convalescent plasma has been widely used to treat COVID-19 and is under investigation in numerous randomized clinical trials, but results are publicly available only for a small number of trials. The objective of this study was to assess the benefits of convalescent plasma treatment compared to placebo or no treatment and all-cause mortality in patients with COVID-19, using data from all available randomized clinical trials, including unpublished and ongoing trials (Open Science Framework, https://doi.org/10.17605/OSF.IO/GEHFX ). Methods In this collaborative systematic review and meta-analysis, clinical trial registries (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform), the Cochrane COVID-19 register, the LOVE database, and PubMed were searched until April 8, 2021. Investigators of trials registered by March 1, 2021, without published results were contacted via email. Eligible were ongoing, discontinued and completed randomized clinical trials that compared convalescent plasma with placebo or no treatment in COVID-19 patients, regardless of setting or treatment schedule. Aggregated mortality data were extracted from publications or provided by investigators of unpublished trials and combined using the Hartung–Knapp–Sidik–Jonkman random effects model. We investigated the contribution of unpublished trials to the overall evidence. Results A total of 16,477 patients were included in 33 trials (20 unpublished with 3190 patients, 13 published with 13,287 patients). 32 trials enrolled only hospitalized patients (including 3 with only intensive care unit patients). Risk of bias was low for 29/33 trials. Of 8495 patients who received convalescent plasma, 1997 died (23%), and of 7982 control patients, 1952 died (24%). The combined risk ratio for all-cause mortality was 0.97 (95% confidence interval: 0.92; 1.02) with between-study heterogeneity not beyond chance (I2 = 0%). The RECOVERY trial had 69.8% and the unpublished evidence 25.3% of the weight in the meta-analysis. Conclusions Convalescent plasma treatment of patients with COVID-19 did not reduce all-cause mortality. These results provide strong evidence that convalescent plasma treatment for patients with COVID-19 should not be used outside of randomized trials. Evidence synthesis from collaborations among trial investigators can inform both evidence generation and evidence application in patient care

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

Abstract Background Convalescent plasma has been widely used to treat COVID-19 and is under investigation in numerous randomized clinical trials, but results are publicly available only for a small number of trials. The objective of this study was to assess the benefits of convalescent plasma treatment compared to placebo or no treatment and all-cause mortality in patients with COVID-19, using data from all available randomized clinical trials, including unpublished and ongoing trials (Open Science Framework, https://doi.org/10.17605/OSF.IO/GEHFX ). Methods In this collaborative systematic review and meta-analysis, clinical trial registries (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform), the Cochrane COVID-19 register, the LOVE database, and PubMed were searched until April 8, 2021. Investigators of trials registered by March 1, 2021, without published results were contacted via email. Eligible were ongoing, discontinued and completed randomized clinical trials that compared convalescent plasma with placebo or no treatment in COVID-19 patients, regardless of setting or treatment schedule. Aggregated mortality data were extracted from publications or provided by investigators of unpublished trials and combined using the Hartung–Knapp–Sidik–Jonkman random effects model. We investigated the contribution of unpublished trials to the overall evidence. Results A total of 16,477 patients were included in 33 trials (20 unpublished with 3190 patients, 13 published with 13,287 patients). 32 trials enrolled only hospitalized patients (including 3 with only intensive care unit patients). Risk of bias was low for 29/33 trials. Of 8495 patients who received convalescent plasma, 1997 died (23%), and of 7982 control patients, 1952 died (24%). The combined risk ratio for all-cause mortality was 0.97 (95% confidence interval: 0.92; 1.02) with between-study heterogeneity not beyond chance (I2 = 0%). The RECOVERY trial had 69.8% and the unpublished evidence 25.3% of the weight in the meta-analysis. Conclusions Convalescent plasma treatment of patients with COVID-19 did not reduce all-cause mortality. These results provide strong evidence that convalescent plasma treatment for patients with COVID-19 should not be used outside of randomized trials. Evidence synthesis from collaborations among trial investigators can inform both evidence generation and evidence application in patient care